KIAA1755 and B-cell chronic lymphocytic leukemia: The aim of our study was to analyze the expression pattern of lnc-IRF2-3 and lnc-KIAA1755-4 in a cohort of unselected CLL patients before the initiation of treatment and to assess the association of their individual expression levels with clinical and laboratory features, established prognostic markers and survival.